Poll Deals Another Major Blow to Congress At least 3 dead after UPS aircraft crashes departing Louisville airport: Officials George Clooney Reveals Why He and Amal Have 'Never Had a Fight' During ...

Choosing a college has been a journey of discovery for Naperville North soccer star Lily Radek. The junior defender had to look within herself in order to figure out where to go. “The whole recruiting ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — Riding high on the success of its blockbuster weight loss drug, Eli ...

Corey Dambacher was working in Oregon when he discovered a type of ribonucleic acid capable of creating unique types of proteins that express themselves on the surfaces of cancer cells. It’s just the ...

Eli Lilly LLY1.26%increase; green up pointing triangle said it plans to build a $6.5 billion facility in Houston to make active pharmaceutical ingredients, including for a new oral weight-loss drug.

Eli Lilly's shares have increased by about 10% over the past month. Clinical progress in the past few weeks has helped solidify its lead in the weight loss market. The company's prospects remain ...

Eli Lilly LLY0.82%increase; green up pointing triangle said new data from its Phase 3 trial of its investigational diabetes pill showed positive results in improving blood sugar levels, outperforming ...

Eli Lilly (NYSE:LLY) on Tuesday announced it will invest $5B to build a new manufacturing facility in Virginia as part of the weight loss drugmaker’s plans to add four new manufacturing sites within ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

As the oral GLP-1 race intensifies, Eli Lilly has slimmed back the number of phase 2 trials it is conducting for one of its contenders. The Big Pharma had been running three midstage studies of the ...

Eli Lilly and Co.’s experimental obesity pill helped patients lose 9.6% of their body weight in a trial that moves the company one step closer to a potential approval. The company’s shares rose as ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Eli Lilly (NYSE:LLY) has quickly emerged as one of Wall ...